Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
Bullboard Posts
User Avatar Image
(14)
•••
Comment by INVESTOR1999on Jul 17, 2019 3:56pm
99 Views
Post# 29931420

RE:RE:RE:RE:RE:RE:RE:RE:My Guess

RE:RE:RE:RE:RE:RE:RE:RE:My GuessSir Gaan. Respectively, your information is inaccurate.  The bought deal was filled at a discounted price at the time with various institutions. Once they have purchased the shares they willl then look for buyers. If they don’t get Buyers, they are stuck with their shares and the price may continue to drop (which they have) and they continue to sell at a loss. Bought deals are risky for the institutions. Simple.  THERE ARE JUST TOO MANY SHARES ON THE OPEN MARKET.  LET ME SPELL IT OUT FOR YOU. - DILUTION 



gaan56 wrote: You truely believe that the investors who  bought into the financing are selling at a loss???? 
If you do, you better invest  your $$$ in Bonds. 

First the shares bought in the latest finacing have a lock up period, and secondly, these big investors who acquired these shares will sell when the houses that financed the deal,start pumpoing the stock.     


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities